The global chronic kidney disease market size is valued at USD 38.91 billion in 2024 and is expected to reach USD 67.36 billion by 2035, representing a CAGR of 5.12% during the forecast period. Chronic kidney disease (CKD) refers to the long-term condition in which a patient gradually loses its kidney function. In most cases, patients suffering from chronic kidney disease remain undiagnosed until the kidney function declined to 75% as its symptoms are rarely observed (which include swollen ankle...

The global retinal biologics market size is currently valued at $ 25.65 billion and is poised to reach $ 57.47 billion by 2035, it is estimated to grow at a CAGR of 7.61%, during the forecast period. There has been a surge in the number of patients suffering from various retinal diseases, such as diabetic retinopathy, glaucomatous retinal degeneration and age-related macular degeneration. As per the World Health Organization, in 2023, nearly 2.2 billion people have near, or distance vision impai...

The smart inhalers market size is valued at USD 1.53 billion in 2024 and is expected to reach USD 5.84 billion by 2035, representing a CAGR of 12.95% during the forecast period 2024-2035. According to our projection, currently hospital pharmacies occupy the highest share (nearly 45%) of the market owing to flexibility, convenience and comfort of purchasing smart inhalers in the healthcare settings for hospitalized patients. Furthermore, there is an increase in the number of hospitalized patients...

The global drug delivery technologies market is currently valued at $0.52 billion and is poised to reach $6.42 billion by 2035, at a CAGR of 25.5%, during the forecast period. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on not only the prescribed therapeutic regimen, but also on numerous hospital visits for dose administration. Since 2018, more than 250 biologics (including antibody d...

Viral sensitizers market, a notable segment of the viral manufacturing consumables market, is anticipated to grow at a compounded annual growth rate (CAGR) of 14% during the forecast period. Over the last two decades, the gene therapy industry has witnessed several breakthroughs including the FDA approval of Abecma for the treatment of adult patients with relapsed or refractory multiple myeloma and the commercialization approval of Libmeldy

The global surgical sutures market is estimated to grow from $4.79 billion in 2024 to $8.70 billion by 2035, at a steady CAGR of 5.57% during the forecast period. In September 2024, Meril announced the launch of New Edge suture that has enhanced durability, precision and reliability and minimizes the risk of complication and re-surgery. Further, in October 2024, Globus Medical announced the launch of TENSOR

The global patient engagement software market is estimated to be worth $8.12 billion in 2024 and is anticipated to grow at a CAGR of 19.57% during the forecast period, till 2035. The current patient engagement software providers landscape features around 345 large, mid-sized and small companies. It is worth mentioning close to 90% of the software providers offer appointment management software and over 95% of the software providers offer services to healthcare providers as their end-users. Cloud...

The global healthcare IT market size is worth around USD 370 billion in 2024 and is expected to reach USD 1,674 billion by 2035. It is expected to grow at a CAGR of 14.7% during the forecast period till 2035. Financial investments in the global healthcare IT market are also on the rise. For instance, Corrections NZ has invested $5 million in EHR systems to enhance their operational efficiency. Moreover, companies like Cerebral have reported a significant reduction in the time spent on audits by...

The global stem cell manufacturing market for contract manufacturers is estimated to grow from USD 76 million in 2026 to USD 279 million by 2035. It is anticipated to grow at a healthy CAGR of 15.6% during the forecast period. According to the report of the National Institute of Health, in 2024, nearly 2,001,140 new cases of cancer have been diagnosed, and around 611,720 deaths have been projected to occur in the US due to cancer. Further, the report of the Centered for Disease Control and Prev...

The vaccines market size is currently valued at $48 billion and is projected to reach $94 billion by 2030, representing a CAGR of 11.9% during the forecast period till 2030. The above sales exclude COVID-19 sales. The outbreak of infectious diseases worldwide has underscored the requirement of advanced vaccines to prevent the risk of diseases. In June 2024, the World Health Organization released a report on the disease outbreaks indicating the increasing number of individuals affected by Avian i...

The global biomaterials market is currently worth around USD 193 billion and is expected to reach USD 442 billion by 2035. It is expected to grow at a CAGR of 7.9% during the forecast period till 2035. The global market for biomaterials is experiencing significant growth, driven by several key trends including increasing adoption of biocompatible materials in medical devices and implants, with advancements in material science enhancing their performance characteristics. North America is emerging...

Global expenditure on veterinary healthcare has been on the rise, driven by various factors such as increased pet ownership, growing disposable income, and the rising willingness of people to spend on their pets' well-being. The veterinary healthcare industry has experienced substantial growth worldwide. In October 2023, Pirbright and VIDO announced the expansion of their collaboration to advance vaccine manufacturing to drive innovations for animal health. Additionally, in February 2022, Dyadic...

The botox market, valued at USD 5.1 billion in 2025, is projected to grow to USD 5.6 billion in 2026 and USD 13.7 billion by 2035, representing a CAGR of 10.4% during the forecast period. Given the need and rising number for botox treatments with each passing year, botox injection manufacturers are also emerging. Owing to the rising focus on facial aesthetics, growing number of skincare clinics, rising influence from the social media influencers, the botulinum toxin market, which is a significan...

Botanicals, also known as botanical medicines, are plant-derived substances valued for their medicinal or therapeutic properties, flavor, and scent. The botanicals market presents significant opportunities driven by increasing consumer preference for natural and organic products, rising awareness of the health benefits of botanicals, and their diverse applications in food and beverage, dietary supplements, personal care products, and cosmetics. Based on applications, the botanicals market is ana...

The global intravenous immunoglobulin market, valued at USD 14.4 billion in 2024, is projected to reach USD 15.6 billion in 2025 and USD 32.3 billion by 2035, representing a CAGR of 7.6% during the forecast period. FDA has till now approved at least 12 human IVIg for treatment of several disorders. It is worth highlighting that Yimmugo, developed by Biotest, is the most recent intravenous immunoglobulin to receive approval in the United Kingdom for the treatment of patients with congenital and a...

The collaborative robot market size is worth USD 2.3 billion in 2024 and is expected to reach USD 10.4 billion by 2030, representing a CAGR of 14.9% during the forecast period. the The integration of artificial intelligence, machine learning technologies, and 5G technologies has positively influenced the industries to stay productive while maintaining quality and efficacy. In fact, it is estimated that collaborative robots and human interaction can enhance the working efficiency of industrial op...

The biopesticides market, valued at USD 8.22 billion in 2025, is projected to reach USD 9.00 billion in 2026 and USD 20.46 billion by 2035, representing a CAGR of 9.6% during the forecast period. The major biopesticides market growth drivers include growth in seed treatment solutions and increase in integrated pest management (IPM) for crop cultivation. Seed treatment forms a chemical barrier between the seed and the external environment, protecting the seed and enhancing plant vigor. Presently,...

The global total lab automation market, valued at USD 670 million in 2025, is projected to reach USD 746 million in 2026 and USD 2,502 million by 2035, with a 14.4% CAGR during the forecast period 2026 to 2035. Total lab automation is an advanced approach that aims to streamline and optimize laboratory processes by integrating various instruments, devices and software into a unified system. Presently, more than 45 total lab automation companies are engaged in offering various automated instr...

The global skincare market size is projected to grow from US$184 billion in 2024 to US$407 billion by 2035, representing a CAGR of 7.5%, during the forecast period, till 2035. The skincare industry is a dynamic and rapidly evolving sector that plays a crucial role in enhancing the health and appearance of skin for consumers worldwide. Since 1970s, technological advancements in terms of manufacturing capabilities, advanced product formulators and customer relationship management tools have propel...

The global SARM1 inhibitor market size is estimated to be worth USD 5 million in 2033 and is expected to reach USD 727 million by 2040, growing at a CAGR of 102% during the forecast period. According to a United Nations report, nearly 1 billion people around the world suffer from various neurological conditions. Further a WHO report states that the U.S. alone spends more than USD 655 billion every year on neurological disorders. Consequently, the rising incidence of neurological disorders has ex...